Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124045762 | 12404576 | 2 | F | 201209 | 20160715 | 20160525 | 20160721 | EXP | US-PFIZER INC-2016274093 | PFIZER | 67.00 | YR | F | Y | 75.00000 | KG | 20160721 | LW | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124045762 | 12404576 | 1 | PS | LIPITOR | ATORVASTATIN CALCIUM | 1 | Oral | 10-20 MG, DAILY | U | 20702 | FILM-COATED TABLET | ||||||||
| 124045762 | 12404576 | 2 | SS | LIPITOR | ATORVASTATIN CALCIUM | 1 | U | 20702 | FILM-COATED TABLET | ||||||||||
| 124045762 | 12404576 | 3 | SS | LIPITOR | ATORVASTATIN CALCIUM | 1 | U | 20702 | FILM-COATED TABLET | ||||||||||
| 124045762 | 12404576 | 4 | SS | LIPITOR | ATORVASTATIN CALCIUM | 1 | U | 20702 | FILM-COATED TABLET | ||||||||||
| 124045762 | 12404576 | 5 | SS | ATORVASTATIN CALCIUM. | ATORVASTATIN CALCIUM | 1 | Oral | 20 MG, DAILY | U | 20702 | 20 | MG | FILM-COATED TABLET | ||||||
| 124045762 | 12404576 | 6 | C | GABAPENTIN. | GABAPENTIN | 1 | 600 MG, 3X/DAY | 0 | 600 | MG | TID | ||||||||
| 124045762 | 12404576 | 7 | C | GABAPENTIN. | GABAPENTIN | 1 | 300 MG, DAILY | 0 | 300 | MG | |||||||||
| 124045762 | 12404576 | 8 | C | CELEBREX | CELECOXIB | 1 | 200 MG, DAILY | 0 | 200 | MG |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124045762 | 12404576 | 1 | Low density lipoprotein increased |
| 124045762 | 12404576 | 2 | Cardiovascular event prophylaxis |
| 124045762 | 12404576 | 3 | Blood cholesterol increased |
| 124045762 | 12404576 | 4 | Blood cholesterol abnormal |
| 124045762 | 12404576 | 5 | Blood cholesterol abnormal |
| 124045762 | 12404576 | 6 | Neuropathy peripheral |
| 124045762 | 12404576 | 8 | Arthritis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 124045762 | 12404576 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124045762 | 12404576 | Type 2 diabetes mellitus |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124045762 | 12404576 | 1 | 2003 | 2012 | 0 | |
| 124045762 | 12404576 | 5 | 2014 | 0 | ||
| 124045762 | 12404576 | 6 | 2007 | 0 | ||
| 124045762 | 12404576 | 7 | 2007 | 0 | ||
| 124045762 | 12404576 | 8 | 2010 | 0 |